Added to YB: 2025-10-28
Pitch date: 2025-10-25
NVO [bullish]
Novo Nordisk A/S
-27.73%
current return
Author Info
HatedMoats identifies hated moats. I buy companies when the market panics. Contrarian investor focused on quality, value & long-term growth. Sign up for the newsletter.
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.1T
Pitch Price
DKK 327.78
Price Target
99.00 (-58%)
Dividend
4.94%
EV/EBITDA
7.46
P/E
10.29
EV/Sales
3.74
Sector
Pharmaceuticals
Category
value
Novo Nordisk (NVO): DCF Valuation
NVO: DCF yields DKK 637 ($99) price target vs DKK 360 current, 44% margin of safety. 70% obesity market share, 44.2% EBIT margin, 63.9% ROIC. Base case: 10.2% 10yr revenue CAGR to DKK 750B by 2034, margins compress to 40%. Bear case DKK 318 only 12% below current price, bull DKK 1,150. Market pricing bear case as likely outcome.
Read full article (6 min)